{"id":"NCT01331681","sponsor":"Bayer","briefTitle":"Intravitreal Aflibercept Injection in Vision Impairment Due to DME","officialTitle":"A Randomized, Double Masked, Active Controlled, Phase III Study of the Efficacy and Safety of Repeated Doses of Intravitreal VEGF Trap-Eye in Subjects With Diabetic Macular Edema","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-05-09","primaryCompletion":"2013-06-03","completion":"2015-03-30","firstPosted":"2011-04-08","resultsPosted":"2014-09-09","lastUpdate":"2023-11-27"},"enrollment":406,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus","Macular Edema"],"interventions":[{"type":"BIOLOGICAL","name":"VEGF Trap-Eye (BAY86-5321)","otherNames":[]},{"type":"BIOLOGICAL","name":"VEGF Trap-Eye (BAY86-5321)","otherNames":[]},{"type":"PROCEDURE","name":"Macular Laser Photocoagulation (Control)","otherNames":[]}],"arms":[{"label":"Intravitreal Aflibercept Injection 2Q4","type":"EXPERIMENTAL"},{"label":"Intravitreal Aflibercept Injection 2Q8","type":"EXPERIMENTAL"},{"label":"Macular Laser Photocoagulation (Control)","type":"ACTIVE_COMPARATOR"}],"summary":"To determine the efficacy of intravitreally (IVT) administered VEGF Trap-Eye on the best-corrected visual acuity (BCVA) assessed by the early treatment diabetic retinopathy study (ETDRS) chart in subjects with diabetic macular edema (DME) with central involvement","primaryOutcome":{"measure":"Change From Baseline in BCVA (Best Corrected Visual Acuity) as Measured by Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score at Week 52 - Last Observation Carried Forward (LOCF)","timeFrame":"Baseline up to Week 52","effectByArm":[{"arm":"Intravitreal Aflibercept Injection 2Q4","deltaMin":10.5,"sd":9.55},{"arm":"Intravitreal Aflibercept Injection 2Q8","deltaMin":10.7,"sd":9.32},{"arm":"Control","deltaMin":1.2,"sd":10.65}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":73,"countries":["Australia","Austria","Czechia","Denmark","France","Germany","Hungary","Italy","Japan","Poland","Spain"]},"refs":{"pmids":["37007927","35843487","35440699","25012934","26198808","26056030","37007930","36265076","29785301","29051325","28006063","27847634"],"seeAlso":["https://clinicaltrials.bayer.com/study/91745"]},"adverseEventsSummary":{"seriousAny":{"events":63},"commonTop":["Nasopharyngitis","Conjunctival haemorrhage","Visual acuity reduced","Cataract","Diabetic retinal oedema"]}}